BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25166914)

  • 1. Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2.
    Bao Y; Chen Z; Guo Y; Feng Y; Li Z; Han W; Wang J; Zhao W; Jiao Y; Li K; Wang Q; Wang J; Zhang H; Wang L; Yang W
    PLoS One; 2014; 9(8):e105991. PubMed ID: 25166914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-656-3p inhibits colorectal cancer cell migration, invasion, and chemo-resistance by targeting sphingosine-1-phosphate phosphatase 1.
    Zhang B; Gao S; Bao Z; Pan C; Tian Q; Tang Q
    Bioengineered; 2022 Feb; 13(2):3810-3826. PubMed ID: 35081855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.
    Ruoming W; Zhen Y; Tengteng Z; Jisheng H
    Cancer Gene Ther; 2015 Dec; 22(12):564-72. PubMed ID: 26494556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ
    Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis.
    Park SY; Kim H; Yoon S; Bae JA; Choi SY; Jung YD; Kim KK
    Mol Ther; 2014 Sep; 22(9):1653-64. PubMed ID: 24909917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.
    Colangelo T; Polcaro G; Ziccardi P; Pucci B; Muccillo L; Galgani M; Fucci A; Milone MR; Budillon A; Santopaolo M; Votino C; Pancione M; Piepoli A; Mazzoccoli G; Binaschi M; Bigioni M; Maggi CA; Fassan M; Laudanna C; Matarese G; Sabatino L; Colantuoni V
    Cell Death Dis; 2016 Feb; 7(2):e2120. PubMed ID: 26913609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting roles of KLF5 in myocardial infarction in mice involving microRNA-27a suppression and the following GFPT2/TGF-β/Smad2/3 axis activation.
    Tian Z; Zhang Y; Lyu X
    Cell Cycle; 2021 May; 20(9):874-893. PubMed ID: 33910455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Zhao J; Xu J; Zhang R
    Oncol Rep; 2018 Feb; 39(2):633-642. PubMed ID: 29207180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
    Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
    J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
    Wu L; Shi B; Huang K; Fan G
    Oncol Rep; 2015 Nov; 34(5):2797-805. PubMed ID: 26352220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosome‑mediated circ‑HMGCS1 via the miR‑34a‑5p/SGPP1 axis.
    He J; Zhao H; Liu X; Wang D; Wang Y; Ai Y; Yang J
    Oncol Rep; 2020 Dec; 44(6):2429-2442. PubMed ID: 33125091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transcriptional regulation of the tumor suppressor p53 by a novel miR-27a, with implications during hypoxia and tumorigenesis.
    Maqbool R; Lone SN; Ul Hussain M
    Biochem J; 2016 Oct; 473(20):3597-3610. PubMed ID: 27531966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.
    Wen J; Liu X; Qi Y; Niu F; Niu Z; Geng W; Zou Z; Huang R; Wang J; Zou H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):428. PubMed ID: 31665064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.
    Toden S; Okugawa Y; Buhrmann C; Nattamai D; Anguiano E; Baldwin N; Shakibaei M; Boland CR; Goel A
    Cancer Prev Res (Phila); 2015 May; 8(5):431-43. PubMed ID: 25712055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-23a promotes the transition from indolent to invasive colorectal cancer.
    Jahid S; Sun J; Edwards RA; Dizon D; Panarelli NC; Milsom JW; Sikandar SS; Gümüs ZH; Lipkin SM
    Cancer Discov; 2012 Jun; 2(6):540-53. PubMed ID: 22628407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.